CME on ReachMD

CME on ReachMD

  • The Changing Landscape of Alzheimer’s Disease: Screening, Diagnosis, and Management for Optimal Patient Outcomes

    Dec 12, 2013 | 53 min
    CME credits: 1.00 Valid until: 02/08/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6673 Join us as Drs. Lah, Hu and Levey discuss the new recommendations and guidelines for AD and emergent biomarkers/imaging as a critical adjunct to earlier identification and management of AD.
  • Overactive Bladder: A Case-Based Approach to Successful Strategies in Evaluation and Treatment

    Dec 12, 2013 | 31 min
    CME credits: 0.50 Valid until: 04/04/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6665 Join us as Dr. Andrea Singer addresses how physicians can identify and overcome barriers that hinder increasing the screening rate of women for OAB, as well as explore the pharmacologic and non-pharmacologic treatment strategies for this condition.
  • Optimizing Fetal Outcomes: The Evolving Role of Noninvasive Prenatal Screening

    Nov 11, 2013 | 25 min
    CME credits: 0.50 Valid until: 11/11/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6857 Noninvasive prenatal screening utilizing DNA technology offers tremendous potential as a screening tool for fetal aneuploidy. Both ACOG and ACMG have recently published guidelines surrounding the use of NIPS. Please join Dr. Susan Gross as she explains the benefits and limitations of NIPS and diagnostic testing options.
  • Diagnosing and Managing Hospitalized Patients with Hyponatremia: Optimizing Outcomes

    Sep 20, 2013 | 30 min
    CME credits: 0.50 Valid until: 09/20/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6785 Please join our three panelists, Drs. Hauptman, Janicic and Zacks, as each discusses hyponatremia in reference to their patients with heart failure, syndrome of inappropriate antidiuretic hormone (SIADH), or cirrhosis, respectively. Issues relating to diagnosis, treatment, and potential complications will be discussed.
  • Improving the Journey of Patients with Migraine: A Focus on Management and Collaborative Care

    Jul 31, 2013 | 27 min
    CME credits: 0.50 Valid until: 07/31/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6795 This panel discussion incorporates both the primary care and headache specialist's points-of-view and stresses co-management practices that optimize outcomes for this often debilitating condition.
  • Management of Ulcerative Colitis: The Role of 5-ASAs

    Jun 25, 2013 | 18 min
    CME credits: 0.25 Valid until: 06/25/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6769 5-ASA therapy is the foundation of treatment for patients with ulcerative colitis; however, suboptimal dosing and lack of patient adherence are common. This CME interview will discuss identification of first-line 5-ASA treatment as well as 5-ASA therapy's value for patients in whom the benefits diminish over time, and incorporation of established approaches to improving patient adherence and compliance.
  • SHIFTWORK SLEEP DISORDER: A WAKE-UP CALL Impact on Health, Safety, and Performance

    Jun 11, 2013 | 31 min
    CME credits: 0.50 Valid until: 06/11/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6703 According to the Centers for Disease Control and Prevention, shiftwork sleep disorder (SWSD) poses a serious heath burden, because it places patients at an unacceptable risk for developing or exacerbating various comorbid conditions (e.g. cardiovascular disease, diabetes, gastrointestinal problems, depression, etc.), as well as having negative effects on performance, safety, and quality of life.
  • Evolving Treatment Paradigms in T2DM: Role of GLP-1 Receptor Agonists

    May 31, 2013 | 28 min
    CME credits: 0.50 Valid until: 05/31/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6746 The goal of glycemic treatment of patients with type 2 diabetes mellitus (T2DM) is to maintain optimal glycemic control, while causing as few adverse consequences as possible. GLP-1-based therapies represent an important advance in the treatment of T2DM, restoring the diminished incretin effect and potentially addressing the decline in beta-cell function.
  • Touchpoints of Multispecialty Care: A Year in the Life of Patients With Atrial Fibrillation

    Dec 11, 2012 | 20 min
    CME credits: 0.25 Valid until: 12/11/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6633 Join us as our panelists address implementing antiarrhythmic strategies over the short- and long-term, including evidence-based medical interventions and surgical ablation, all within the confines of a well-rounded management approach including anticoagulant therapy.
  • Collaborative Post Fracture Management

    Oct 29, 2012 | 29 min
    CME credits: 0.50 Valid until: 10/29/2014 Claim your CME credit at http://www.reachmd.com/cmedetails.aspx?sid=6624 Join us as our panel discusses fracture management, including prevention strategies that strive to optimize outcomes for patients at risk for/following low trauma fracture. Our faculty also addresses mechanisms to improve the interdisciplinary collaboration and communication so necessary when providing a high standard-of-care to our patients with osteoporosis.

Chat About This Show